• 1. Excellent electrochemical performance of LiFe0.4Mn0.6PO4 microspheres produced using a double carbon coating process?
  Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
• 2. Distribution pattern and allocation of defects in hydrogenated ZnO thin films?
  Vitaly Gurylev,Chung-Yi Su,Tsong-Pyng Perng Phys. Chem. Chem. Phys., 2016,18, 16033-16038
• 3. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
• 4. Distribution and ecological risk assessment of typical antibiotics in the surface waters of seven major rivers, China?
  Environ. Sci.: Processes Impacts, 2021,23, 1088-1100
• 5. Enantiomeric helical TiO2 nanofibers modulate different peptide assemblies and subsequent cellular behaviors?
  Xu Jie,Deng Xu,Weili Wei RSC Adv., 2019,9, 29149-29153

Introduction to 3-ethynyl-1-(propan-2-yl)-1H-pyrazole (CAS No. 1354706-26-5)

3-ethynyl-1-(propan-2-yl)-1H-pyrazole, identified by the Chemical Abstracts Service Number (CAS No.) 1354706-26-5, is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the pyrazole class, a scaffold that is widely recognized for its diverse biological activities and potential therapeutic applications. The presence of both an ethynyl and an isopropyl substituent on the pyrazole ring introduces unique electronic and steric properties, making it a valuable candidate for further exploration in drug discovery.

The structural features of 3-ethynyl-1-(propan-2-yl)-1H-pyrazole contribute to its reactivity and functionalization capabilities. The ethynyl group, characterized by a triple bond to carbon, can participate in various chemical reactions such as Sonogashira coupling, allowing for the introduction of additional aryl or vinyl groups. This property is particularly useful in constructing more complex molecular architectures, which is often required in the development of novel therapeutic agents. The isopropyl group, on the other hand, provides steric hindrance and can influence the compound's solubility and binding affinity to biological targets.

In recent years, there has been a growing interest in pyrazole derivatives due to their broad spectrum of biological activities. These activities include anti-inflammatory, antimicrobial, antiviral, and anticancer properties. The 3-ethynyl-1-(propan-2-yl)-1H-pyrazole molecule has been investigated for its potential role in modulating various biological pathways. For instance, studies have suggested that this compound may interact with enzymes and receptors involved in inflammation and cancer progression.

One of the most compelling aspects of 3-ethynyl-1-(propan-2-yl)-1H-pyrazole is its versatility in medicinal chemistry applications. Researchers have explored its use as a building block for more complex molecules through techniques such as palladium-catalyzed cross-coupling reactions. These reactions allow for the efficient construction of biaryl structures, which are commonly found in many bioactive compounds. Additionally, the compound's ability to undergo further functionalization makes it a valuable tool for synthesizing analogs with tailored biological properties.

The pharmacological profile of 3-ethynyl-1-(propan-2-yl)-1H-pyrazole has been the subject of several preclinical studies. These studies have focused on evaluating its interactions with key biological targets such as kinases and transcription factors. Preliminary findings indicate that this compound may exhibit inhibitory effects on certain enzymes implicated in diseases like cancer and inflammation. However, further research is necessary to fully elucidate its mechanism of action and therapeutic potential.

The synthesis of 3-ethynyl-1-(propan-2-yl)-1H-pyrazole involves multi-step organic transformations that highlight the compound's synthetic accessibility. Key steps include the preparation of the pyrazole core followed by selective functionalization at the 3-position with an ethynyl group and at the 1-position with an isopropyl group. Advances in synthetic methodologies have enabled more efficient and scalable production processes, making it feasible to conduct larger-scale studies.

In conclusion, 3-ethynyl-1-(propan-2-yl)-1H-pyrazole (CAS No. 1354706-26-5) represents a promising candidate for further exploration in pharmaceutical research. Its unique structural features, combined with its potential biological activities, make it an attractive molecule for drug discovery efforts. As our understanding of its pharmacological properties continues to grow, this compound may play a significant role in the development of new therapeutic strategies.

• 647824-46-2(1-tert-Butyl-3,5-dimethyl-1H-pyrazole)
• 61514-59-8(3-ethynyl-1-methyl-1H-pyrazole)
• 1249088-67-2(1-(tert-Butyl)-5-methyl-1H-pyrazole)
• 160729-58-8(1-isopropyl-3-methyl-1H-pyrazole)
• 1172938-74-7(1-(butan-2-yl)-3-methyl-1H-pyrazole)
• 30433-57-9(1-Ethyl-3-methyl-1H-pyrazole)
• 67759-35-7(1H-PYRAZOLE, METHYL(1-METHYLETHYL)-)
• 1007515-32-3(1-(1-Isopropyl-1H-pyrazol-3-yl)methanamine)
• 191089-20-0(1-tert-Butyl-3-methyl-1H-pyrazole)
• 79168-93-7(3,5-dimethyl-1-(propan-2-yl)-1H-pyrazole)